Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Rosiglitazone

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 18,300Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Type 2 diabetes drug Rosiglitazone increases risk of heart problems
    Type 2 diabetes drug Rosiglitazone increases risk of heart problems

    13 Feb 2020

    // PHARMAFILE

    http://www.pharmafile.com/news/541395/type-2-diabetes-drug-rosiglitazone-increases-risk-heart-problems

    PHARMAFILE
    13 Feb 2020
    Share Share
    New study adds to evidence of diabetes drug link to heart problems
    New study adds to evidence of diabetes drug link to heart problems

    06 Feb 2020

    // PRESS RELEASE

    https://www.bmj.com/company/newsroom/new-study-adds-to-evidence-of-diabetes-drug-link-to-heart-problems/

    PRESS RELEASE
    06 Feb 2020
    Share Share
    The Most Wonderful Mistake the FDA Ever Made
    The Most Wonderful Mistake the FDA Ever Made

    07 Dec 2018

    // Milton Packer MEDPAGE TODAY

    https://www.medpagetoday.com/blogs/revolutionandrevelation/76713

    Milton Packer MEDPAGE TODAY
    07 Dec 2018
    Share Share
    New Diabetes Drugs Will Still Require CV Outcomes Trials
    New Diabetes Drugs Will Still Require CV Outcomes Trials

    06 Nov 2018

    // John LaMattina FORBES

    https://www.forbes.com/sites/johnlamattina/2018/11/06/no-matter-what-the-fda-decides-new-diabetes-drugs-will-still-require-cv-outcomes-trials/?ss=healthcare#36f072145098

    John LaMattina FORBES
    06 Nov 2018
    Share Share
    FDA Experts May Reconsider Diabetes Drug Safety Rules
    FDA Experts May Reconsider Diabetes Drug Safety Rules

    26 Oct 2018

    // Matthew Herper FORBES

    https://www.forbes.com/sites/matthewherper/2018/10/24/fda-experts-may-reconsider-diabetes-drug-safety-rules/#2e4c1b2a76d7

    Matthew Herper FORBES
    26 Oct 2018
    Share Share
    Novel Diabetes Drugs Sensitize Cancer Cells to Chemotherapy Agents
    Novel Diabetes Drugs Sensitize Cancer Cells to Chemotherapy Agents

    02 Jan 2018

    // DDDMAG

    https://www.dddmag.com/news/2018/01/novel-diabetes-drugs-sensitize-cancer-cells-chemotherapy-agents

    DDDMAG
    02 Jan 2018
    Share Share